Carole Helissey

13PUBLICATIONS
124CO-AUTHORS
Radiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Dec 12, 2024
Correlation Between Electronic Patient-Reported Outcomes and Biological Markers of Key Parameters in Acute Radiation Cystitis Among Patients With Prostate Cancer (RABBIO): Prospective Observational Study.

Carole Helissey, Sophie Cavallero, Nathalie Guitard

|Sep 28, 2024
[18F]FDG PET/CT Integration in Evaluating Immunotherapy for Lung Cancer: A Clinician's Practical Approach.

Juliette Brezun, Nicolas Aide, Evelyne Peroux

|May 11, 2024
Revolutionizing Localized Lung Cancer Treatment: Neoadjuvant Chemotherapy plus Immunotherapy for All?

Victoria Ferrari, Carole Helissey

|Jun 26, 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.

Naoual Menssouri, Loïc Poiraudeau, Carole Helissey

|May 27, 2023
Revolutionizing Radiotoxicity Management with Mesenchymal Stem Cells and Their Derivatives: A Focus on Radiation-Induced Cystitis.

Carole Helissey, Sophie Cavallero, Nathalie Guitard

|Jan 10, 2023
Correlation Between Serum and Urine Biomarkers and the Intensity of Acute Radiation Cystitis in Patients Treated With Radiation Therapy for Localized Prostate Cancer: Protocol for the Radiotoxicity Bladder Biomarkers (RABBIO) Study.

Carole Helissey, Sophie Cavallero, Stanislas Mondot

Pageof 3

Frequent Collaborators

4 joint publications

Charles Parnot

3 joint publications

Cyrus Chargari

3 joint publications

Sophie Cavallero

3 joint publications

Antoine Schernberg